Aspire Biopharma holder reports 7.92% stake

Lance Friedman reports beneficial ownership of common stock of Aspire Biopharma Holdings, Inc. on an amended Schedule 13G. He is a United States citizen and lists 25 N Market Street, Suite 205, Jacksonville, Florida as his address.

Rhea-AI Filing Summary

Lance Friedman reports beneficial ownership of common stock of Aspire Biopharma Holdings, Inc. on an amended Schedule 13G. He is a United States citizen and lists 25 N Market Street, Suite 205, Jacksonville, Florida as his address. Friedman reports beneficial ownership of 107,323 shares of common stock, representing 7.92% of the class, with sole voting and sole dispositive power over all 107,323 shares and no shared power. The holdings include 107,323 shares of common stock with a floor price of $7.92 per share. He also holds preferred stock that is convertible into common stock but subject to a 9.99% ownership blocker, which prohibits conversion if it would cause his ownership to exceed 9.99% of Aspire Biopharma’s outstanding common stock.

Key Figures

Beneficially owned shares: 107,323 shares Percent of class: 7.92 % Floor price per share: $7.92 per share +1 more

4 metrics

Beneficially owned shares 107,323 shares Common stock beneficially owned by Lance Friedman

Percent of class 7.92 % Percentage of Aspire Biopharma common stock class beneficially owned

Floor price per share $7.92 per share Floor price for 107,323 common shares referenced in the comment

Ownership blocker threshold 9.99 % Preferred stock conversion blocked if ownership would exceed this level

Key Terms

beneficially owned, Sole Voting Power, Sole Dispositive Power, convertible into common stock, +1 more

5 terms

beneficially owned financial

"Ownership (a) | Amount beneficially owned (b) | Percent of class: 7.92 %"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"5 | Sole Voting Power 3,979,709.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"7 | Sole Dispositive Power 3,979,709.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

convertible into common stock financial

"Preferred Stock convertible into common stock with which contain a blocker"

blocker financial

"contain a blocker prohibiting their conversion if it would result"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of Aspire Biopharma (ASBP) does Lance Friedman report owning?

Lance Friedman reports beneficial ownership of 7.92% of Aspire Biopharma’s common stock, based on 107,323 shares. This percentage reflects his reported beneficial holdings, including his sole voting and dispositive power over those shares.

How many Aspire Biopharma (ASBP) shares does Lance Friedman beneficially own?

Lance Friedman reports beneficial ownership of 107,323 shares of Aspire Biopharma common stock. He has sole voting and sole dispositive power over all of these shares, with no shared voting or dispositive authority reported.

What is the floor price mentioned for Lance Friedman’s Aspire Biopharma (ASBP) shares?

Friedman’s reported holdings include 107,323 shares of Aspire Biopharma common stock with a floor price of $7.92 per share. This floor price applies to those common shares referenced in the ownership comment section.

Does Lance Friedman hold convertible preferred stock in Aspire Biopharma (ASBP)?

Yes. The filing states that Friedman also holds preferred stock convertible into common stock. These preferred shares are subject to a blocker that limits conversion if it would raise his ownership above a specified threshold.

What is the ownership blocker on Lance Friedman’s Aspire Biopharma (ASBP) preferred stock?

The preferred stock held by Friedman contains a 9.99% ownership blocker. This provision prohibits conversion of the preferred shares into common stock if doing so would cause him to own more than 9.99% of Aspire Biopharma’s outstanding common stock.

Does Lance Friedman share voting or dispositive power over Aspire Biopharma (ASBP) shares?

No. Friedman reports sole power to vote and to dispose of 107,323 Aspire Biopharma common shares. The Schedule 13G/A lists no shared voting power and no shared dispositive power for these securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 08:48 PM Accepted by SEC EDGAR 08/06/2026 - 08:47 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 9)

Aspire Biopharma Holdings, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

738920305

(CUSIP Number)

08/04/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 738920305

1

Names of Reporting Persons

Lance Friedman

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,979,709.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,979,709.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

107,323.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.92 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Includes 107,323 shares of common stock shares with a floor price of $7.92 per share. The Reporting Person also has Preferred Stock convertible into common stock with which contain a blocker prohibiting their conversion if it would result in the holder owning more than 9.99% of the outstanding common stock.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Aspire Biopharma Holdings, Inc.
(b)	Address of issuer's principal executive offices: 194 Candelaro Drive, #233, Humacao, Puerto Rico, 00791
Item 2.
(a)	Name of person filing: Lance Friedman
(b)	Address or principal business office or, if none, residence: 25 N Market Street, Suite 205, Jacksonville, Florida 32202
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 738920305
Item 4.	Ownership
(a)	Amount beneficially owned:
(b)	Percent of class: 7.92 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 107,323
	(ii) Shared power to vote or to direct the vote: N/A
	(iii) Sole power to dispose or to direct the disposition of: 107,323
	(iv) Shared power to dispose or to direct the disposition of: N/A
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lance Friedman

Signature:	/s/ Lance Friedman
Name/Title:	Lance Friedman
Date:	08/06/2026